The estimated annual hemorrhagic risk for unruptured AVMs in children is 6.3%, significantly higher than in adults (2–4%) [22]. In some series, the total mortality rate caused by ruptured AVMs in children is as high as 21% [11]. In addition, as patients age, AVMs may undergo dynamic morphological changes and develop associated aneurysms, venous malformations, and venous stenosis. Additionally, the longer expectation of life in children further increases their risk of AVM rupture and intracranial hemorrhage[23]. Studies showed that 49% of children with AVM rupture presented with severe disability (mRS > 3) and/or required emergency hematoma evacuation [24], and all children with AVMs must bear the psychological burden of the disease, which may cause neurological damage or even death at any time in their life. Young women must also anticipate an increased risk of intracranial hemorrhage during pregnancy [25]. The higher annual risk of AVM rupture with associated increased complications and morbidity as well as the significant cumulative lifetime risk in children demonstrates the value of AVM obliteration in this population. In our opinion, regardless of rupture status, all AVMs in children should be evaluated for potential treatment. Previous studies have demonstrated favorable clinical outcomes after pediatric AVM treatment relative to adults [26, 27], which may be attributed to greater neuroplasticity in children [26].
Multidisciplinary review and the use of a balanced multimodality approach in the management of pediatric brain AVMs can improve treatment outcomes, reduce procedure-related morbidity and mortality. It has been reported that AVMs of SM I-II grade are low-risk lesions that can be safely treated by microsurgery, and 92–100% of patients have obtained good results[28]. At the same time, in the case of acute AVM rupture complicated with large hematoma, the AVM can be surgically removed together with the hematoma. For AVMs above SM grade III, microsurgery alone had high risk, and required multiple models or treatments. Endovascular embolization is also a common treatment for AVMs, which can be used to occlude AVMs as a simple treatment. It can also be used as an adjunct to surgery or radiosurgery. Pre-operative endovascular embolization can reduce the volume of AVMs and reduce the risk of blood flow-related aneurysm rupture in endovascular, while reducing blood theft and related complications. During microsurgery, the embolization provides a bloodless surgical plane for surgical resection and avoids sacrificing the parenchyma for hemostasis manipulations. The embolic agents act as markers of arterial feeders, preventing inadvertent damage to nearby arteries.
Few studies have examined outcomes in AVM pediatric patients treated in a hOR [29, 30]. Our retrospective study included 13 AVM pediatric patients who underwent one-stop hybrid treatment. Compared with microsurgery group, hOR patients had smaller intraoperative blood loss (P < 0.001), operation time (P < 0.001) and postoperative hospital stay (P = 0.024), which showed the advantages of the hybrid operation in AVMs for children. Univariate analysis showed that the presence of neurological dysfunction (P = 0.026) and S-M grade (P = 0.047) may be relevant factors for predicting the surgical approach. The results of multivariate analysis showed that the probability of patients choosing composite surgery was 3.046 times that of microsurgery for each step of increase in S-M grade, indicating that the higher the S-M grade was, the higher the probability of choosing hybrid operation was. It indicated that hybrid operation should be selected for high-grade AVMs in children.
The advantages of the one-staged hOR for treating AVMs were proposed [20], including (1) preoperative embolization helps to reduce the blood flow of the nidus, (2) could avoid additional anesthesia of subsequent operations, (3) the extent of AVM obliteration can be observed immediately, (4) avoids the transportation of patients between the intervention room and the operating room, and can effectively reduce the anesthesia risk during transportation, and (6) patients' medical expenses could be reduced due to the operation completed under anesthesia only once. Rutledge et al. reported that using hOR could improve the cure rate and reduce the incidence of AVMs [31]. Grüter et al performed routine DSA after AVM operation through a hOR, and found two cases of residual malformed vascular masses during the operation, followed by remedial resection, and one case successfully underwent surgical resection with preoperative embolization to reduce blood flow of the AVM [20]. Song et al. used hOR to treat low-grade and high-grade AVMs, significantly reducing the risk of postoperative rebleeding [32].
All the studies in this group were completed in hOR. The results showed that there were no significant differences in age, initial symptoms, presence of neurological dysfunction, GCS score, Hunt-Hess classification, and intraventricular hemorrhage between the two groups. Those suggest that the baseline situation before surgery is basically the same between the two groups. Only the proportion of female patients in the hybrid operation group was higher than that in the microsurgery group (8/25 vs 9/13). The proportion of AVMs located on the supratentorial (P = 0.034) and the proportion of S-M above grade III (P = 0.003) in the hybrid operation group were higher than those in the microsurgery group. There was no significant difference in postoperative cure rate in imaging, incidence of postoperative complications, and mRS 3 months and 6 months after operation. It indicated that although the complexity of AVMs treated in the hybrid operation group was higher than that in the microsurgery group, the prognosis could reach the same level.